Gladstone and Lundbeck Collaborate to Study Neurovascular Disease and Identify Novel Therapeutic Strategies
Gladstone and Lundbeck Collaborate to Study Neurovascular Disease and Identify Novel Therapeutic Strategies
SAN FRANCISCO, CA—The Gladstone Institutes and the international pharmaceutical company H. Lundbeck A/S have announced a collaborative research agreement to study and identify therapeutic candidates for neurological diseases.
Akassoglou Lab Multiple Sclerosis